Instrument Inactif

Communiqués Conformis, Inc.

Actions

CFMS

US20717E2000

Equipement, fournitures et distribution médicale

Communiqués

05/09/23	Restor3d Completes Acquisition of Conformis	AQ
05/09/23	Conformis : Termination of Material Agreement - Form 8-K	PU
23/08/23	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
21/08/23	Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d	AQ
02/08/23	ConforMIS: Q2 Earnings Snapshot	AQ
02/08/23	Conformis Reports Second Quarter 2023 Financial Results	AQ
25/06/23	CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS	BU
23/06/23	Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash	AQ
19/05/23	Conformis : CONSULTING AGREEMENT - Form 8-K	PU
10/05/23	CONFORMIS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
08/05/23	CONFORMIS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
08/05/23	CONFORMIS INC : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
08/05/23	ConforMIS: Q1 Earnings Snapshot	AQ
08/05/23	Conformis Reports First Quarter 2023 Financial Results	AQ
13/04/23	Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023	AQ
21/03/23	Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures	AQ
08/03/23	Conformis : Investor Presentation	PU
01/03/23	ConforMIS: Q4 Earnings Snapshot	AQ
01/03/23	CONFORMIS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
01/03/23	Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results	AQ
21/02/23	Conformis, Inc. to Participate in Upcoming Investor Conferences	AQ
15/02/23	Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation	AQ
10/02/23	Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022	AQ
23/01/23	Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022	AQ
30/11/22	CONFORMIS INC : Other Events (form 8-K)	AQ